Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04936659 · ClinicalTrials.gov registry record · NA
Effect of Palpatory Neuromodulation of the Trigeminal Nerve for Tenderness in the Posterior Neck Musculature
A NA study, sponsored by University of North Texas Health Science Center.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT04936659: Completed NA study, sponsored by University of North Texas Health Science Center.
NCT04936659 is a NA study that has completed, run by University of North Texas Health Science Center. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04936659, a NA study, has completed, sponsored by University of North Texas Health Science Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the extent to which a non-invasive, palpatory neuromodulatory protocol on the trigeminal nerve endings on the face can affect tenderness felt on the posterior neck musculature, using the Isotouch pressure sensor system. Specific Aim 1: Subjects will see a decrease in tenderness in the posterior neck musculature. Specific Aim 2: Subjects will show a decrease in tenderness on the trigeminal tender points found on the face.
Primary Outcome
Palpatory assessment of muscle tenderness measured on a visual analog scale of 0-10
Interventions
- OTHER neuromodulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2017-10-13 |
| Est. Completion | 2020-05-01 |
| Phase | NA |
What the finished NCT04936659 record still lists
NCT04936659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which neuromodulation is the first listed.
NCT04936659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04936659 about?
NCT04936659 is a clinical study titled "Effect of Palpatory Neuromodulation of the Trigeminal Nerve for Tenderness in the Posterior Neck Musculature". The purpose of this study is to assess the extent to which a non-invasive, palpatory neuromodulatory protocol on the trigeminal nerve endings on the face can affect tenderness felt on the posterior neck musculature, using the Isotouch pressure sensor system. Specific Aim 1: Subjects will see a decr...
What is the current status of trial NCT04936659?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2017-10-13. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT04936659?
The interventions under investigation include: neuromodulation (OTHER).
Who is sponsoring clinical trial NCT04936659?
This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04936659's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI